Aims Although alirocumab and evolocumab have both been associated with improved
outcomes in patients with dyslipidaemia or established atherosclerotic cardiovascular disease, …

Dual antiplatelet therapy (DAPT) is the gold standard after acute coronary syndromes (ACS)
or chronic coronary syndromes (CCS) undergoing percutaneous coronary intervention (PCI)…

Background Contemporary data are lacking regarding the prognosis and management of left
ventricular thrombus (LVT). Objectives The purpose of this study was to quantify the effect …

Aims To assess the incidence, risk factors and prognosis of periprocedural myocardial
infarction (MI) and myocardial injury in patients undergoing elective percutaneous coronary …

Abstract Treatment of patients with lung cancer during the current COVID-19 pandemic is
challenging. Lung cancer is a heterogenous disease with a wide variety of therapeutic options. …

A substantial number of chronic coronary syndrome (CCS) patients undergoing percutaneous
coronary intervention (PCI) experience periprocedural myocardial injury or infarction. …

Methods From February 25 to June 25, 2020, 20 patients were admitted in our institution for
clinically suspected acute or fulminant myocarditis (viral, 16 patients; autoimmune, three …

Introduction COVID-19 infection is commonly complicated with pro-thrombotic state and
endothelial dysfunction. While several studies reported a high incidence of venous …

Background Percutaneous coronary intervention (PCI)-related myonecrosis is frequent and
can affect the long-term prognosis of patients. To our knowledge, ticagrelor has not been …

This is the fourth version of the updated guidelines for the diagnosis and management of
asthma, developed by the Saudi Initiative for Asthma (SINA) group, a subsidiary of the Saudi …